Protagonist Therapeutics (PTGX) PT Raised to $91 at Clear Street
Tweet Send to a Friend
Clear Street analyst Kaveri Pohlman raised the price target on Protagonist Therapeutics (NASDAQ: PTGX) to $91.00 (from $74.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
